Foley hosted a breakfast briefing program addressing the latest trends in health care financings and mergers and acquisitions (M&A). This informal session was led by Michael L. Blau of Foley’s Health Care Industry Team and Gabor Garai and Todd L. Boudreau of Foley’s Private Equity & Venture Capital Practice. The session was comprised of two interactive panel discussions, one of which will focus on sector-specific opportunities and the other of which will focus on stages of financing for health care companies.
Sector panelists included:
- Ted Ashburn, M.D., Ph.D., Senior Director of Corporate Development, Genzyme Corporation
- Patrick Ryan, CEO, PolyMedica Corporation
- William McPhee, Director, Health Advances, LLC
Financing panelists included:
- Eugene Hill, Managing Partner, SV Life Sciences
- Mary McNamara, Managing Director, Angel Healthcare Investors, LLC
- Jon Lemelman, General Partner, Riverside Partners LLC
This panels addressed pertinent topics, including:
- The state of the health care industry
- Investment opportunities and future trends in pharmaceuticals/biotechnology, medical device, health services, and health care information technology
- Transformational technologies for which to watch
- Financing strategies and solutions
- Investment criteria by stage of growth
- Health care exit and liquidity alternatives
- Effective acquisition and integration strategies
- International health care M&A and global challenges
“What is Hot in Healthcare Financings and M&A” is part of Foley’s 2007 Boston Executive Briefings Series.
People
Related Insights
25 February 2025
Events
Navigating Tariffs and Supply Chain Contracts: Mitigating Financial and Legal Risks
Join Foley and Lardner LLP partners Greg Husisian, Leah Imbrogno, and Vanessa Miller on Tuesday, February 25, for a Strafford CLE webinar, “Navigating Tariffs and Supply Chain Contracts: Mitigating Financial and Legal Risks.”
17 February 2025
Foley Viewpoints
Navigating Non-Compete Agreements: Key Considerations for In-House Counsel in Franchise Businesses
In May of last year, the Federal Trade Commission (FTC) sought to ban non-compete agreements in most employment contracts. Franchise agreements were an exception. However, before the rule could take effect in September, a federal court vacated the ruling in August, asserting that the FTC lacked the authority to enforce such a regulation.
17 February 2025
Renewed Prohibition on Use of Sub-Regulatory Guidance – Key to False Claims Act Cases
“It’s déjà vu all over again.” Attorney General Pam Bondi has not surprisingly renewed the prior Trump administration’s prohibition on the use of sub-regulatory guidance, potentially altering the landscape for False Claims Act cases pursued during the second Trump administration.